Condition
Fuchs' Endothelial Dystrophy clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Fuchs' Endothelial Dystrophy clinical trials that are recruiting, at sites in 7 countries (most in United States (4), Singapore (2), Mexico (1)). By phase: Phase 1 (3), Phase 4 (2), Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 7Countries
Newest Fuchs' Endothelial Dystrophy clinical trials
All recruiting trials (10)
-
EO2002 therapy for corneal edema due to endothelial dysfunction
This trial tests whether a single intracameral injection of EO2002 cells can improve vision and reduce corneal thickness in adults with corneal edema from endothelial dysfunction.
-
PVEK corneal implant to treat corneal swelling
This study will test a PVEK tissue‑engineered corneal implant to see if it is safe and helps people with corneal swelling from Fuchs' endothelial dystrophy or pseudophakic bullous keratopathy who need endothelial keratoplasty.
-
Understanding Fuchs' Endothelial Corneal Dystrophy and its Genetic Links
This study is trying to understand how Fuchs' Endothelial Corneal Dystrophy affects younger people with a genetic link to the condition by using advanced imaging to track changes over time.
-
Using plasma rich in growth factors during corneal transplants
This study tests if using plasma rich in growth factors during corneal transplants can help patients keep more healthy cells after surgery compared to standard methods.
-
Effects of Ripasudil on Patients with Fuchs' Endothelial Dystrophy Undergoing Cataract Surgery
This study is testing if a new eye drop called ripasudil can help people with Fuchs' Endothelial Dystrophy have better results after cataract surgery.
-
OPTIMISE — safer steroid plans after DMEK cornea transplant
This study tests whether using a milder steroid eye drop plan or stopping steroids earlier after DMEK can still prevent graft rejection while reducing the risk of high eye pressure in adults receiving corneal transplants.
-
Assessing the safety of EO2002 injections for corneal conditions
This study is testing if EO2002 injections are safe for people with corneal conditions like Fuchs' dystrophy or pseudophakic bullous keratopathy.
-
Tissue-engineered endothelial keratoplasty with lab-grown corneal endothelial grafts
This trial will test whether a graft made from lab-grown human corneal endothelial cells can safely restore vision in adults with mild to moderate corneal endothelial failure such as Fuchs' dystrophy or bullous keratopathy.
-
Using Glanatec® to treat Fuchs' Endothelial Dystrophy
This study is testing if Glanatec®, a glaucoma medication, can help clear corneal cells in people with Fuchs' Endothelial Dystrophy who have had a specific eye surgery.
-
Testing Brillouin Microscopy for Diagnosing Corneal Conditions
This study is testing a new imaging technique called Brillouin microscopy to see if it can better diagnose corneal issues like keratoconus and ectasia in people.
Related topics
Quick answers
How many Fuchs' Endothelial Dystrophy clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (4 trials), Singapore (2 trials), Mexico (1 trial), United Kingdom (1 trial), Armenia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 4: 2, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.